May. 21 at 8:05 AM
$NRXP Since that bullish, Israeli, campaign poster from NRx (side note: the CEO's son, who runs the website and social media agenda from Tel Aviv, got twice as much money in 2025, i.e.
$200,000) has blocked me but still wants to read my posts: The BoD is observing, not operating but @DavidBG knows that. I don't see how that's supposed to be a good argument for why Ketafree will be commercially successful even without a ban on BZT. But he has never exactly shone when it comes to coming up with his own(!) arguments. One need to remember that PharmaTher received an upfront payment plus a
$25 million milestone payment. That's what the ANDA is worth. Anyway, Chaim is at least one of the insiders who invested his own money in this company. And he happens to be one of the last ones. In August 2023.
A parting word to you, David: Sweetie, you really need to let go of me. You've already blocked me, but you're still reading my posts.Come on, Honey, let go. Bye bye.
